Zhang X, Jeyakumar M, Bagchi M K
Population Council and the Rockefeller University, New York, New York 10021, USA.
J Biol Chem. 1996 Jun 21;271(25):14825-33.
Steroid and thyroid hormone receptors exhibit striking structural and functional similarity, suggesting that these nuclear receptors may enhance transcription of target genes by similar mechanisms. To address this issue, we studied transcriptional interference between progesterone and thyroid hormone receptors in vivo and in vitro. We observed that transcriptional interference occurred in a ligand-dependent manner between progesterone receptor-B (PR-B) and thyroid hormone receptor (TR) alpha or beta in transient transfection experiments. Ligand-occupied TRalpha or TRbeta, but not the unliganded receptor, strongly suppressed transactivation of a progesterone-responsive reporter gene by endogenous PRs in human breast carcinoma T47D cells. Ligand-dependent inhibitory cross-talk also occurred between transfected PR-B and TRalpha or TRbeta and vice versa in CV1 cells. This phenomenon did not require DNA binding by the "interfering" receptor but required it to be hormone-bound, indicating that a transcriptionally active form of the interfering receptor is essential for the interfering effect. To analyze further the mechanism of the ligand-dependent cross-talk, we reproduced transcriptional interference between PR and TR in a cell-free transcription system. We observed that the addition of triiodothyronine-bound recombinant TRbeta or a ligand binding domain (LBD) peptide(145-456) inhibited specifically transcriptional activation of a progesterone-responsive gene by endogenous PRs in nuclear extracts of T47D cells, while the basal level of transcription from a minimal TATA-promoter or transcription from an adenovirus major-late promoter remained unaffected. These results indicated that a transactivation function within the LBD of the interfering receptor TRbeta was likely to interact with a mediator protein(s), termed coactivator, that is distinct from basal transcription factors and is critical for efficient PR-induced transactivation. This concept was reinforced by biochemical evidence that treatment of T47D extracts with immobilized TRbeta LBD depleted the extract of the coactivator function in a triiodothyronine-dependent manner and markedly impaired progesterone-induced transactivation of progesterone response element-linked genes. Deletion of six amino acids(451-456) in the extreme COOH terminus of TRbeta resulted in a receptor that retained the ability to bind thyroid hormone but failed to inhibit progesterone-dependent transcription. Interestingly, these six amino acids are present in a region that is highly conserved among various nuclear hormone receptors and contains a ligand-dependent transactivation function, AF-2. Based on these results, we propose that a limiting coactivator protein(s) interacts with the AF-2 of PR or TR and mediates transactivation by the ligand-bound receptor. This regulatory molecule(s) may therefore serve as a common functional link between the pathways of hormone-inducible gene activation by various members of the nuclear receptor superfamily.
类固醇和甲状腺激素受体表现出显著的结构和功能相似性,这表明这些核受体可能通过相似的机制增强靶基因的转录。为了解决这个问题,我们在体内和体外研究了孕酮受体与甲状腺激素受体之间的转录干扰。我们观察到,在瞬时转染实验中,孕酮受体-B(PR-B)与甲状腺激素受体(TR)α或β之间以配体依赖的方式发生转录干扰。配体结合的TRα或TRβ,而非未结合配体的受体,强烈抑制人乳腺癌T47D细胞中内源性PRs对孕酮反应性报告基因的反式激活。在CV1细胞中,转染的PR-B与TRα或TRβ之间也发生了配体依赖的抑制性串扰,反之亦然。这种现象不需要“干扰”受体与DNA结合,但需要其与激素结合,这表明干扰受体的转录活性形式对于干扰效应至关重要。为了进一步分析配体依赖串扰的机制,我们在无细胞转录系统中重现了PR与TR之间的转录干扰。我们观察到,添加结合了三碘甲状腺原氨酸的重组TRβ或配体结合结构域(LBD)肽(145-456)可特异性抑制T47D细胞核提取物中内源性PRs对孕酮反应性基因的转录激活,而最小TATA启动子的基础转录水平或腺病毒主要晚期启动子的转录不受影响。这些结果表明,干扰受体TRβ的LBD内的反式激活功能可能与一种称为共激活因子的介导蛋白相互作用,该共激活因子不同于基础转录因子,对于PR诱导的有效反式激活至关重要。生化证据进一步支持了这一概念,即用固定化的TRβ LBD处理T47D提取物以三碘甲状腺原氨酸依赖的方式耗尽了提取物的共激活因子功能,并显著损害了孕酮诱导的孕酮反应元件连接基因的反式激活。TRβ极端COOH末端六个氨基酸(451-456)的缺失导致一种受体,该受体保留了结合甲状腺激素的能力,但无法抑制孕酮依赖的转录。有趣的是,这六个氨基酸存在于一个在各种核激素受体中高度保守的区域,并且包含一个配体依赖的反式激活功能,即AF-2。基于这些结果,我们提出一种有限的共激活因子蛋白与PR或TR的AF-2相互作用,并介导配体结合受体的反式激活。因此,这种调节分子可能作为核受体超家族各成员激素诱导基因激活途径之间的共同功能联系。